Rapid advancements in molecular diagnostics are drawing the attention of the bioscience industry, regulatory agencies, clinicians, patients and insurers alike. This survey course provides a foundation in the basic science and technologies that underlie the emerging field of molecular diagnostics, and highlights potential impacts on the healthcare landscape.
Interactive lectures explore the intricate relationship between the human genome and diagnostic tests. The instructor addresses the growing importance of personalized medicine, and touches upon the role of pharmacogenomics in the development of new therapeutics and treatment options. She uses case studies to present the applications of molecular diagnostic tools in infectious disease identification and early detection and diagnosis of cancer.
Professional Credit: CA BRN/LVN Credit--Provider #CEP13114.